Dana-Farber wins legal dispute over PD-1/PD-L1 patents; BMS set to lose exclusive license May 24, 2019Vol.45 No.21By Paul Goldberg
Drugs & Targets FDA approves Bavencio + Inlyta combination in renal cell carcinoma May 17, 2019Vol.45 No.20
Drugs & Targets GE Healthcare and Indi Molecular partner on diagnostic tool for immunotherapy patients May 17, 2019Vol.45 No.20
Clinical Roundup ASCO announces top studies to be presented at 2019 annual meeting May 17, 2019Vol.45 No.20
Clinical Roundup Earlier, more frequent removal of some pancreatic cysts may decrease cancer risk May 17, 2019Vol.45 No.20
